Severe Dupilumab-Associated Ocular Surface Disease: Multicenter Experience and Management Considerations.
PURPOSE To evaluate severe dupilumab-associated ocular surface disease (DAOSD) and identify clinical features, risk factors, and outcomes associated with delayed ophthalmologic referral. METHODS A multicenter retrospective case series of 13 patients (26 eyes) with severe DAOSD presenting to tertiary centers between J...